Elevation Oncology, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Elevation Oncology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.15M, a 36.9% increase year-over-year.
  • Elevation Oncology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $3.39M, a 13.4% decline year-over-year.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $3.34M, a 4.02% increase from 2022.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.21M, a 104% increase from 2021.
  • Elevation Oncology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $1.57M, a 2921% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $3.34M +$129K +4.02% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 $3.21M +$1.64M +104% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 $1.57M +$1.52M +2921% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $52K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.